Birth Control Pills Recalled Due to Danger of Unintended Pregnancy

Share this content:
Birth Control Pills Recalled Due to Danger of Unintended Pregnancy
Birth Control Pills Recalled Due to Danger of Unintended Pregnancy

FRIDAY, June 9, 2017 (HealthDay News) -- One lot of Mibelas 24 Fe birth control pills has been recalled due to a packaging error that could put users at risk of unintended pregnancy, according to manufacturer Lupin Pharmaceuticals.

The recall is for lot L600518, Exp 05/18 of Mibelas 24 Fe (Norethindrone Acetate and Ethinyl Estradiol 1 mg/0.02 mg chewable and ferrous fumarate 75 mg), the Baltimore-based company said.

In this lot, the blister is rotated 180 degrees within the wallet, reversing the weekly tablet orientation and making the lot number and expiration date no longer visible. The first four days of therapy would have four non-hormonal placebo tablets as opposed to the active tablets, putting the user at risk for contraceptive failure and unintended pregnancy.

Consumers with the recalled lot should notify their physician and return the product to the pharmacy or place of purchase. For more information, contact the company at 1-800-399-2561.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »